Heavy-light chain mispairing is one of the major concerns for producing bispecific antibodies. bYlok™ technology is a design engineering approach that solves this whist retaining molecule's closer-to-nature structure and simplified downstream purification.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content
Latest briefing from the Knowledge Center